从非传统的5'起点转移导致瘤开始
Ataman Sendoel1, Joshua G Dunn2, Edwin H Rodriguez2
1Robin Chemers Neustein Laboratory of Mammalian Development and Cell Biology, Howard Hughes Medical Institute, The Rockefeller University, New York, New York 10065, USA.
癌细胞通过使用替代的翻译起点来劫持蛋白质合成,特别是在致癌信使RNA (mRNA) 的5'未翻译区域. 这一过程由替代启动因子eIF2A驱动,提供新的治疗点.
科学领域:
- 分子生物学
- 癌症生物学
- 遗传学
背景情况:
- 转化控制显著影响瘤发病和恶性瘤.
- 了解癌症转化调节的具体机制对于开发有效疗法至关重要.
研究的目的:
- 通过体内模型研究从正常平衡转变为恶性瘤的转化情况.
- 确定参与癌症进展的关键转化调节剂.
主要方法:
- 在诱导性SOX2和瘤性RAS的小鼠模型中使用了表皮特异性,体内核糖体分析策略.
- 在体内进行了转化调节者的RNA干扰选.
- 分析了eIF2和eIF2A等特定翻译启动因子的作用.
主要成果:
- 尽管蛋白质合成总体减少,但在瘤开始时,某些致癌mRNA被优先翻译.
- 转化器被重定向到非传统的上游启动部位,从而提高了致癌mRNA的转化效率.
- 常规eIF2复合物的耗尽损害了正常生长,但并没有损害瘤生长.
- 替代启动因子eIF2A对癌症进展至关重要,它调解了上游启动和歪曲蛋白质表达.
结论:
- 在癌症的发展中发挥关键作用.
- 替代翻译启动,特别是通过eIF2A,是瘤发生的一个关键机制.
- 这些发现揭示了癌症干预的新疗法目标.
更多相关视频
05:06Tumor Allotransplantation in Drosophila melanogaster with a Programmable Auto-Nanoliter Injector
Published on: February 2, 2021
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
相关概念视频
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Leaky Scanning
Cancers Originate from Somatic Mutations in a Single Cell
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
